Heart patients get stronger combo pill after stent surgery
NCT ID NCT05782777
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether taking ezetimibe along with a high-dose statin (atorvastatin) works better than the statin alone for people who have had a heart stent placed. About 4,300 participants will be followed for three years to see if the combination reduces deaths, heart attacks, strokes, or the need for more procedures. The goal is to lower LDL cholesterol more aggressively and improve long-term heart health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ezetimibe and atorvastatin (combination therapy) versus atorvastatin alone
What this could lead to
If it works, this could show that adding ezetimibe to a high-dose statin reduces the risk of heart attacks, strokes, and death after stent placement.
What could go wrong
This is a large but early-stage trial with no phase designation. The benefit may be small or not outweigh the risks of side effects like muscle pain or liver issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE REQUIRING CORONARY REVASCULARIZATION WITH NEWER GENERATION DES IMPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••